Brief: Biosynex FY Revenue Down At 196.6 Million Euros

Biosynex SA

19/01/2023 17:19

Jan 19 (Reuters) - Biosynex SA  ALBIO.PA :
    * FY REVENUE EUR 196.6 MILLION VERSUS EUR 382.5 MILLION YEAR
AGO
    * OUTLOOK: FOR 2023, THE GROUP ANTICIPATES THE CONTINUED
DECLINE
IN ACTIVITY AROUND COVID-19 PRODUCTS
    * COVID-19 PRODUCTS REVENUE OF €140.9 MILLION IN 2022
COMPARED TO
€342.2 MILLION IN 2021
    * OUTLOOK: WILL CONTINUE ITS POST-PANDEMIC DIVERSIFICATION
EFFORTS
IN 2023 WITH THE AIM OF ESTABLISHING ITS POSITIONS AROUND ITS
THREE MAIN AXES (POINT OF CARE, MOLECULAR BIOLOGY, RAPID
DIAGNOSTIC TESTS)

Source text for Eikon:  ID:nEQ15hsJCa 
Further company coverage:  ALBIO.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))